Phase II Study Examining the Efficacy of Short Fractionation Radiotherapy for the Palliation of Liver Metastases

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

SOCRATES HCC trial - all Australian sites open
5 March, 2025

All Australian sites open for SOCRATES HCC trial

5 March 2025: TRIAL UPDATE We’re excited to have

TROG trial in focus DCIS
4 March, 2025

TRIAL IN FOCUS: DCIS delivers valuable evidence

4 March 2025: A decade on from the last